Accessibility navigation


Antitumor activity of Titanocene Y in xenografted PC3 tumors in mice

Dowling, C.M. , Claffrey, J., Cuffe, S., Fichtner, I., Pampillon, C., Sweeney, N.J., Strohfeldt, K., Watson, R., William, G. and Tacke, M. (2008) Antitumor activity of Titanocene Y in xenografted PC3 tumors in mice. Letters in Drug Design & Discovery, 5 (2). pp. 141-144. ISSN 1570-1808

Full text not archived in this repository.

It is advisable to refer to the publisher's version if you intend to cite from this work. See Guidance on citing.

To link to this item DOI: 10.2174/157018008783928463

Abstract/Summary

Chemotherapeutic options for androgen-independent prostate cancer are extremely limited with minimum survival advantage. The benzyl-substituted unbridged titanocene bis-[(p-methoxybenzyl) cyclopentadienyl] titanium(IV) dichloride (Titanocene Y) was tested in vitro against the human prostate cancer androgen-independent cell, PC-3, which demonstrated an IC50 value of 56 x 10(-6) mol/L compared to 5.6 x 10(-6) mol/L for cisplatin. Then Titanocene Y was given at the maximum tolerable dose of 40 mg/kg/d on five consecutive days to one cohort of eight PC3 tumor-bearing male NMRI: nu/nu mice, while a second cohort was treated similarly with 3 mg/kg/d of cisplatin. Both of these mouse cohorts showed a statistically significant tumor growth reduction with respect to the third solvent-treated control group, which led to T/C values of 42% for cisplatin and 52% for Titanocene Y at the end of the experiment. This encouraging activity of Titanocene Y against prostate tumors in vivo, which is almost comparable with respect to cisplatin hopefully leads to further development of Titanocene Y in the future.

Item Type:Article
Refereed:Yes
Divisions:Faculty of Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy
ID Code:13757
Uncontrolled Keywords:anti-cancer drug, cisplatin, titanocene, prostate cancer, PC-3, xenograft , SUBSTITUTED ANSA-TITANOCENE, POTENTIAL ANTICANCER DRUGS, COLONY-FORMING-UNITS, TITANIUM DICHLORIDE, PROSTATE-CANCER, CYTOTOXICITY, DERIVATIVES, FULVENES, MITOXANTRONE, PREDNISONE

University Staff: Request a correction | Centaur Editors: Update this record

Page navigation